2020
Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection
Hummel JP, Maraj I, Taoutel R, Chamoun R, Workman VK, Tran L, Abboud JM, Afif C, Chouairi S, Delvecchio A, Howes CJ, Enriquez AD, Akar JG. Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection. Circulation Arrhythmia And Electrophysiology 2020, 13: e008841-e008841. PMID: 32931318, PMCID: PMC7566294, DOI: 10.1161/circep.120.008841.Peer-Reviewed Original Research
2018
A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today?
Wolbrette DL, Hussain S, Maraj I, Naccarelli GV. A Quarter of a Century Later: What is Dofetilide’s Clinical Role Today? Journal Of Cardiovascular Pharmacology And Therapeutics 2018, 24: 3-10. PMID: 29940780, DOI: 10.1177/1074248418784288.Peer-Reviewed Original ResearchConceptsAtrial fibrillationAtrial flutterClass III antiarrhythmic agentPost-myocardial infarction patientsAcceptable renal functionAtrioventricular nodal blockadeAcceptable safety profileNormal QT intervalParoxysmal atrial fibrillationReal-world efficacyCreatinine clearanceRenal functionSymptomatic patientsHeart failureAtrial tachycardiaPersistent arrhythmiaSafety profileSinus rhythmAntiarrhythmic agentsInfarction patientsVentricular tachycardiaClinical trialsQT intervalDrug trialsDrug Administration
2017
Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis
Briceño DF, Romero J, Villablanca PA, Londoño A, Diaz JC, Maraj I, Batul SA, Madan N, Patel J, Jagannath A, Mohanty S, Mohanty P, Gianni C, Della Rocca D, Sabri A, Kim SG, Natale A, Di Biase L. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. EP Europace 2017, 20: 104-115. PMID: 28575378, DOI: 10.1093/europace/eux109.Peer-Reviewed Original ResearchConceptsStructural heart diseaseStable ventricular tachycardiaLong-term outcomesVA recurrenceVentricular tachycardiaCause mortalityStandard ablationHeart diseaseExtensive substrate modificationVentricular arrhythmia recurrenceComposite primary outcomeDifferent ablation strategiesIschemic substrateArrhythmia recurrenceIschemic cardiomyopathyPrimary outcomeMAIN OUTCOMESubstrate modificationAblation strategyLower riskElectronic searchPatientsRecurrenceSystematic reviewMortality